Császár A - Search Results

1

Hypertriglyceridemia, the coronary heart disease risk marker "solved".

Császár A. Császár A. Acta Physiol Hung. 2005;92(2):109-20. doi: 10.1556/APhysiol.92.2005.2.2. Acta Physiol Hung. 2005. PMID: 16268049 Review.

2

Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction.

Császár A, Duba J, Melegh B, Kramer J, Szalai C, Prohászka Z, Karádi I, Kovács M, Méhes K, Romics L, Füst G. Császár A, et al. Exp Clin Immunogenet. 2001;18(4):206-12. doi: 10.1159/000049199. Exp Clin Immunogenet. 2001. PMID: 11872951

3

The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.

Kalina A, Császár A, Füst G, Nagy B, Szalai C, Karádi I, Duba J, Prohászka Z, Horváth L, Dieplinger H. Kalina A, et al. Among authors: csaszar a. Clin Chim Acta. 2001 Jul 5;309(1):45-51. doi: 10.1016/s0009-8981(01)00500-9. Clin Chim Acta. 2001. PMID: 11408005 Clinical Trial.

4

Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

Szalai C, Keszei M, Duba J, Prohászka Z, Kozma GT, Császár A, Balogh S, Almássy Z, Fust G, Czinner A. Szalai C, et al. Among authors: csaszar a. Atherosclerosis. 2004 Mar;173(1):109-14. doi: 10.1016/j.atherosclerosis.2003.12.003. Atherosclerosis. 2004. PMID: 15177130

5

Influence of apolipoprotein E genotypes on serum lipid parameters in a biracial sample of children.

Szalai C, Czinner A, Császár A. Szalai C, et al. Among authors: csaszar a. Eur J Pediatr. 2000 Apr;159(4):257-60. doi: 10.1007/s004310050065. Eur J Pediatr. 2000. PMID: 10789929

6

Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects.

Prohászka Z, Duba J, Horváth L, Császár A, Karádi I, Szebeni A, Singh M, Fekete B, Romics L, Füst G. Prohászka Z, et al. Among authors: csaszar a. Eur J Clin Invest. 2001 Apr;31(4):285-92. doi: 10.1046/j.1365-2362.2001.00819.x. Eur J Clin Invest. 2001. PMID: 11298774

7

Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population.

Császár A, Kékes E, Abel T, Papp R, Kiss I, Balogh S. Császár A, et al. Blood Press. 2006;15(2):101-6. doi: 10.1080/08037050600772284. Blood Press. 2006. PMID: 16754273 Free article.

8

Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary.

Kalina A, Császár A, Czeizel AE, Romics L, Szabóki F, Szalai C, Reiber I, Németh A, Stephenson S, Williams RR. Kalina A, et al. Among authors: csaszar a. Atherosclerosis. 2001 Jan;154(1):247-51. doi: 10.1016/s0021-9150(00)00648-1. Atherosclerosis. 2001. PMID: 11137107

9

Vascular pleiosynergy--does it really work?

Császár A. Császár A. Curr Vasc Pharmacol. 2007 Oct;5(4):302-4. doi: 10.2174/157016107782023352. Curr Vasc Pharmacol. 2007. PMID: 17979796 Review.

10

[Distribution of apolipoprotein A I and B in the blood according to age and gender, as well as their relation to blood cholesterol levels in the Hungarian blood donor population].

Császár A, Romics L, Karádi I, Tresch J, Hans-Jürgen M. Császár A, et al. Orv Hetil. 1991 Aug 18;132(33):1795-800. Orv Hetil. 1991. PMID: 1870862 Review. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters